Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
entolimod
(STAT-600) /
Coeptis
Welcome,
Profile
Billing
Logout
33 Diseases
0 Trials
0 Trials
89 News
«
1
2
||||||||||
entolimod
(STAT-600) /
Coeptis
New P1 trial, Metastases:
Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation Therapy
(clinicaltrials.gov) - Nov 15, 2012
P1
, N=0, Withdrawn,
Sponsor: Roswell Park Cancer Institute
||||||||||
entolimod
(STAT-600) /
Coeptis
New P1 trial, Surgery, Metastases:
Entolimod in Treating Patients With Locally Advanced or Metastatic Solid Tumors That Cannot Be Removed By Surgery
(clinicaltrials.gov) - Feb 2, 2012
P1
, N=66, Recruiting,
Sponsor: Roswell Park Cancer Institute